Camonsertib in DNA damage response-deficient advanced solid tumors: phase 1 trial results. Yap TA, Fontana E, Lee EK, Spigel DR, et al. Nat Med 2023;29:1400-1411.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Yap TA, Fontana E, Lee EK, Spigel DR, et al. Camonsertib in DNA damage response-deficient advanced solid tumors: phase 1 trial results. Nat Med 2023;29:1400-1411.
PMID: 37277454